Atlas Trials

Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Clinical trial NCT06856616 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06856616
Sponsor
The Third Affiliated Hospital of Harbin Medical University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Breast Neoplasms
Start date
2025-05-13
Primary completion
2025-11-01
Enrollment
6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.